Tuesday, October 20, 2026 from 10:15 a.m. to 11:45 a.m. MDT at Salt Palace Convention Center - Ballroom E
Available for 1.50 hours of CPE creditActivity Number: 0217-0000-26-157-L01-PActivity Type: An Application-Based ActivityManagement of inflammatory bowel disease (IBD) continues to advance rapidly, with expanding biologic classes, novel small molecules, and evolving strategies for positioning therapy across disease phenotypes. This session will synthesize recent guideline updates, pivotal clinical trial data, and practical considerations for enhancing treatment selection, monitoring, and optimization. Emphasis will be placed on actionable, pharmacy-focused insights to support evidence-based care in both ambulatory and acute care settings.
Learning Objectives1. Summarize current inflammatory bowel disease (IBD) treatment goals.
2. Differentiate emerging therapeutic options used for inflammatory bowel disease management.
3. Interpret recent guideline updates and pivotal clinical trial data to inform acute inpatient management of IBD.
4. Apply guideline recommendations and clinical trial evidence to outpatient IBD management decisions.
5. Analyze treatment positioning and sequencing strategies across IBD therapies based on disease severity, risk stratification, and prior treatment exposure.
6. Design care plans that incorporate individualized and evidence-based treatment strategies for patients with IBD.
 | | Moderator: | Michael A. Rudoni, Jr., Pharm.D., FCCM, BCCCP, BCPS | | Medical ICU Clinical Pharmacist, Critical Care Clinical Coordinator
Cleveland Clinic
Cleveland, OH | | View Biography |
|
IBD Management Reimagined: Decoding Today’s Therapeutic Landscape10:15 a.m. to 10:45 a.m. | | Speaker: | Shubha Bhat, Pharm.D., FCCP, BCACP | | Clinical Pharmacist - Gastroenterology/Hepatology
Cleveland Clinic Foundation
Cleveland, Ohio | | View Biography |
|
|
From Evidence to Action: Navigating Modern IBD Therapeutics10:45 a.m. to 11:15 a.m. | | Speaker: | Gregory M. Zumach, Pharm.D., BCPS | | Clinical Associate Professor, University of Nebraska Medical Center College of Pharmacy;
Clinical Pharmacist, Nebraska Medicine
Omaha, Nebraska | | View Biography |
|
|
Bridging the Gap: Case-Based Decision Making Across the IBD Care Continuum11:15 a.m. to 11:45 a.m. | | Speaker: | David K. Choi, Pharm.D. | | Associate Director
Clinical Pharmacy Specialist
University of Chicago Medicine
Inflammatory Bowel Disease Center
Chicago, Illinois | | View Biography |
|
|